Implementation of a perioperative glycemic management quality improvement pathway in gynecologic oncology patients: a single-cohort interrupted time series analysis

Published:November 24, 2022DOI:
      This paper is only available as a PDF. To read, Please Download here.



      We evaluated implementation and clinical outcomes of a perioperative glycemic management pathway (PGMP) in gynecologic oncology.


      Interrupted times series analysis was used to compare process, balancing, and outcome measures and clinical outcomes from 18-months pre-implementation to 18-months post-implementation.


      Compared to the pre-implementation period, the proportion of patients who underwent preoperative screening with hemoglobin A1c increased by 11.3% (95%CI: 5.0-17.7%; p=0.001). The proportion of patients with diabetes who had at least one blood glucose measurement after surgery increased by 15.3% (95%CI: -3.2-33.8%; p=0.10). There was no change in the proportion of patients who had any hyperglycemia, moderate or severe hyperglycemia. The median length of stay decreased by 0.42 days (95%CI: -0.91-0.07 days; p=0.09).


      There were important quality gaps in perioperative glycemic management that did not clearly improve after implementation of a multidisciplinary care pathway.


      Optimal strategies for improvement of perioperative glycemic management are not yet known.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect